These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. The relation between human lysosomal beta-galactosidase and its protective protein. Hoogeveen AT, Verheijen FW, Galjaard H. J Biol Chem; 1983 Oct 25; 258(20):12143-6. PubMed ID: 6415049 [Abstract] [Full Text] [Related]
25. Intracerebroventricular enzyme replacement therapy with β-galactosidase reverses brain pathologies due to GM1 gangliosidosis in mice. Chen JC, Luu AR, Wise N, Angelis R, Agrawal V, Mangini L, Vincelette J, Handyside B, Sterling H, Lo MJ, Wong H, Galicia N, Pacheco G, Van Vleet J, Giaramita A, Fong S, Roy SM, Hague C, Lawrence R, Bullens S, Christianson TM, d'Azzo A, Crawford BE, Bunting S, LeBowitz JH, Yogalingam G. J Biol Chem; 2020 Sep 25; 295(39):13532-13555. PubMed ID: 31481471 [Abstract] [Full Text] [Related]
31. Processing of human beta-galactosidase in GM1-gangliosidosis and Morquio B syndrome. Hoogeveen AT, Graham-Kawashima H, d'Azzo A, Galjaard H. J Biol Chem; 1984 Feb 10; 259(3):1974-7. PubMed ID: 6420416 [Abstract] [Full Text] [Related]
32. Molecular basis of GM1 gangliosidosis and Morquio disease, type B. Structure-function studies of lysosomal beta-galactosidase and the non-lysosomal beta-galactosidase-like protein. Callahan JW. Biochim Biophys Acta; 1999 Oct 08; 1455(2-3):85-103. PubMed ID: 10571006 [Abstract] [Full Text] [Related]
34. Biosynthesis of the sulfatide/GM1 activator protein (SAP-1) in control and mutant cultured skin fibroblasts. Fujibayashi S, Wenger DA. Biochim Biophys Acta; 1986 Feb 28; 875(3):554-62. PubMed ID: 3081038 [Abstract] [Full Text] [Related]